PhysiologybioRxiv
Reconstituted depolarization-induced Ca2+ release platform for skeletal muscle disease mutation validation and drug discovery
T. Murayama, N. Kurebayashi, T. Numaga-Tomita…·T. Sakurai
The paper establishes a reconstituted DICR platform in HEK293 cells to validate skeletal muscle disease mutations and test drug candidates.
DOI 10.1085/jgp.202213230